Jyoti Meena
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jyoti Meena has a total of 77 co-authors. Here are the top co-authors by number of shared publications:
- Seema Singhal
Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India
6 shared publications Seema Singhal
Department of Obstetrics and Gynecology, All India Institute of Medical Sciences, New Delhi, India
3 shared publicationsSunesh Kumar
Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India
3 shared publications- Sunesh Kumar
Department of Obstetrics & Gynaecology, All India Institute of Medical Sciences, New Delhi, India
3 shared publications - Swati Shivhare
Department of Obstetrics & Gynaecology, All India Institute of Medical Sciences, New Delhi, India
3 shared publications Bhawani Shekhar
Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India
2 shared publications
Latest Publications
- Open Access
- 1 July 2026
- Published by Wolters Kluwer Health in Journal of Mid-life Health
- Vol. 17 (3) , 408-415
Role of Transvaginal Three-dimensional Power Doppler Ultrasound and Hysteroscopy in Postmenopausal Bleeding
A BSTRACT: Background: Postmenopausal bleeding (PMB) is a warning symptom and is associated with endometrial malignancy in 10%–15% of cases. Endometrial thickness (ET) measurement using transvaginal ultrasound (TVS) guides the course of action, with ET >4 mm being ominous. Three-dimensional power Doppler (3DPD) ultrasound raises diagnostic utility with endometrial volume (EV) and vascularity indices-vascularization index (VI), flow Index (FI) and vascularization FI (VFI), while hysteroscopy provides a direct view of uterine lesions. Previous studies have worked on role of 3DPD or hysteroscopy in PMB patients, but none have compared these two. Hence, this study was conducted. Methods: This prospective observational study was conducted at a tertiary center, including 75 women with PMB. They underwent 3DPD ultrasound followed by hysteroscopy and endometrial biopsy. The diagnostic accuracy of Doppler parameters was analyzed using receiver operating characteristic curves. Hysteroscopic results were compared with histopathology, followed by comparison of 3DPD and hysteroscopy. Results: Out of 75 patients, 65 (86.6%) had benign pathologies and 10 (13.4%) had malignancies. 3DPD parameters VI, VFI, and EV were significantly higher in the malignant group. EV had the highest diagnostic performance, with an area under curve (AUC) of 0.88 (cutoff ≥7.34 cm 3 ), yielding 80% sensitivity and 80% specificity. VI, FI, and VFI achieved sensitivity/specificity of 80%/78.5%, 70%/70.8%, and 80%/73.8%, with AUCs of 0.83, 0.69, and 0.82, respectively. Hysteroscopy demonstrated 100% sensitivity and specificity for detecting endometrial malignancy and endometrial polyps. Cohen’s kappa analysis of hysteroscopy and 3DPD showed agreement of 78.67%, 70.67%, 78.67%, and 80% between hysteroscopy and VI, FI, VFI and EV, respectively. Conclusion: 3DPD, particularly EV, is a valuable noninvasive tool in PMB. Hysteroscopy remains a highly sensitive and specific modality for detecting malignancy, showing good correlation with 3DPD.
- 1 July 2026
- Published by Wolters Kluwer Health in Journal of Mid-life Health
- Vol. 17 (3) , 408-415
Open AccessRole of Transvaginal Three-dimensional Power Doppler Ultrasound and Hysteroscopy in Postmenopausal Bleeding
A BSTRACT: Background: Postmenopausal bleeding (PMB) is a warning symptom and is associated with endometrial malignancy in 10%–15% of cases. Endometrial thickness (ET) measurement using transvaginal ultrasound (TVS) guides the course of action, with ET >4 mm being ominous. Three-dimensional power Doppler (3DPD) ultrasound raises diagnostic utility with endometrial volume (EV) and vascularity indices-vascularization index (VI), flow Index (FI) and vascularization FI (VFI), while hysteroscopy provides a direct view of uterine lesions. Previous studies have worked on role of 3DPD or hysteroscopy in PMB patients, but none have compared these two. Hence, this study was conducted. Methods: This prospective observational study was conducted at a tertiary center, including 75 women with PMB. They underwent 3DPD ultrasound followed by hysteroscopy and endometrial biopsy. The diagnostic accuracy of Doppler parameters was analyzed using receiver operating characteristic curves. Hysteroscopic results were compared with histopathology, followed by comparison of 3DPD and hysteroscopy. Results: Out of 75 patients, 65 (86.6%) had benign pathologies and 10 (13.4%) had malignancies. 3DPD parameters VI, VFI, and EV were significantly higher in the malignant group. EV had the highest diagnostic performance, with an area under curve (AUC) of 0.88 (cutoff ≥7.34 cm 3 ), yielding 80% sensitivity and 80% specificity. VI, FI, and VFI achieved sensitivity/specificity of 80%/78.5%, 70%/70.8%, and 80%/73.8%, with AUCs of 0.83, 0.69, and 0.82, respectively. Hysteroscopy demonstrated 100% sensitivity and specificity for detecting endometrial malignancy and endometrial polyps. Cohen’s kappa analysis of hysteroscopy and 3DPD showed agreement of 78.67%, 70.67%, 78.67%, and 80% between hysteroscopy and VI, FI, VFI and EV, respectively. Conclusion: 3DPD, particularly EV, is a valuable noninvasive tool in PMB. Hysteroscopy remains a highly sensitive and specific modality for detecting malignancy, showing good correlation with 3DPD.
- 23 February 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (2) , e266372
Post-hysterectomy presentation of low-grade endometrial stromal sarcoma (LGESS): a clinical challenge in uterine malignancies
Endometrial stromal sarcoma (ESS) is a rare uterine malignancy originating from endometrial connective tissue. It is classified into benign and malignant subtypes. While it primarily affects perimenopausal women aged 45–55 years, younger patients may also be affected. ESS often presents with symptoms such as abnormal uterine bleeding, pelvic pain or pelvic mass, mimicking benign conditions like fibroids. Definitive treatment includes total hysterectomy with bilateral salpingo-oophorectomy, complemented by hormonal therapy for advanced cases. Despite its indolent nature, low-grade ESS (LGESS) requires long-term follow-up due to significant recurrence risk. We present a case of a woman in her late 20s, who underwent hysterectomy for severe bleeding and anaemia, with LGESS diagnosed later during a growing abdominal wall mass evaluation. Imaging and biopsy confirmed her diagnosis. She underwent extensive debulking surgery. Histological analysis revealed oval to spindle cells, low mitotic activity, no necrosis or atypical mitotic figures; Estrogen Receptor (ER), Progesterone Receptor (PR) and CD10 positivity, which were consistent with LGESS.
- 23 February 2026
- Published by BMJ in BMJ Case Reports
- Vol. 19 (2) , e266372
Post-hysterectomy presentation of low-grade endometrial stromal sarcoma (LGESS): a clinical challenge in uterine malignancies
Endometrial stromal sarcoma (ESS) is a rare uterine malignancy originating from endometrial connective tissue. It is classified into benign and malignant subtypes. While it primarily affects perimenopausal women aged 45–55 years, younger patients may also be affected. ESS often presents with symptoms such as abnormal uterine bleeding, pelvic pain or pelvic mass, mimicking benign conditions like fibroids. Definitive treatment includes total hysterectomy with bilateral salpingo-oophorectomy, complemented by hormonal therapy for advanced cases. Despite its indolent nature, low-grade ESS (LGESS) requires long-term follow-up due to significant recurrence risk. We present a case of a woman in her late 20s, who underwent hysterectomy for severe bleeding and anaemia, with LGESS diagnosed later during a growing abdominal wall mass evaluation. Imaging and biopsy confirmed her diagnosis. She underwent extensive debulking surgery. Histological analysis revealed oval to spindle cells, low mitotic activity, no necrosis or atypical mitotic figures; Estrogen Receptor (ER), Progesterone Receptor (PR) and CD10 positivity, which were consistent with LGESS.
- 20 December 2025
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 318, 114901
Prognostic significance of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in predicting response to neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer: a prospective study
- 20 December 2025
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 318, 114901
Prognostic significance of neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in predicting response to neoadjuvant chemotherapy in advanced high-grade serous ovarian cancer: a prospective study
- Open Access
- 28 April 2025
- Published by Medip Academy in International Journal of Reproduction, Contraception, Obstetrics and Gynecology
- Vol. 14 (5) , 1660-1664
Ruptured endometrioma mimicking ovarian malignancy: a case report and literature review
In current practice endometriosis is a rising concern, involving all age groups and relatively less prevalent in perimenopausal age groups. It has a variety of presenting symptoms in perimenopausal age group including severe dysmenorrhoea, dyspareunia, infertility, chronic pelvic pain, abdominopelvic mass, acute abdomen with peritonitis and non-specific symptoms like gastritis, diarrhoea, rectal bleeding. High index of suspicion should be there to diagnose a ruptured endometrioma in a perimenopausal female with adnexal mass, peritonitis features and rising serum CA-125 and CA19.9 levels. Here we present a case of ruptured endometrioma mimicking ovarian malignancy in a perimenopausal female.
- 28 April 2025
- Published by Medip Academy in International Journal of Reproduction, Contraception, Obstetrics and Gynecology
- Vol. 14 (5) , 1660-1664
Open AccessRuptured endometrioma mimicking ovarian malignancy: a case report and literature review
In current practice endometriosis is a rising concern, involving all age groups and relatively less prevalent in perimenopausal age groups. It has a variety of presenting symptoms in perimenopausal age group including severe dysmenorrhoea, dyspareunia, infertility, chronic pelvic pain, abdominopelvic mass, acute abdomen with peritonitis and non-specific symptoms like gastritis, diarrhoea, rectal bleeding. High index of suspicion should be there to diagnose a ruptured endometrioma in a perimenopausal female with adnexal mass, peritonitis features and rising serum CA-125 and CA19.9 levels. Here we present a case of ruptured endometrioma mimicking ovarian malignancy in a perimenopausal female.
- Open Access
- 1 January 2025
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 36 (6)
Current status and challenges in training the next generation of gynecologic cancer care providers in Asia
Meena J, et al. J Gynecol Oncol. 2025 Apr;36:e103. https://doi.org/10.3802/jgo.2025.36.e103
- 1 January 2025
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 36 (6)
Open AccessCurrent status and challenges in training the next generation of gynecologic cancer care providers in Asia
Meena J, et al. J Gynecol Oncol. 2025 Apr;36:e103. https://doi.org/10.3802/jgo.2025.36.e103
- Open Access
- 18 December 2024
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 22 (1) , 1-8
Patterns of care for vulvar cancer and insights from revised FIGO staging: a retrospective study
The objective of this study was to evaluate the clinicopathological characteristics and patterns of care among women diagnosed with vulvar malignancy at a tertiary care teaching institute. Additionally, the study aimed to analyse the implications of revised FIGO staging system on stage shift and patient outcomes. A retrospective observational study was conducted, wherein hospital records of biopsy-proven cases of vulvar cancers managed over a period of 10 years were comprehensively reviewed. The assignment of FIGO staging was performed utilizing both 2009 and 2021 FIGO staging systems for comparative analysis. Statistical analysis was performed using STATA version 17. Survival curves were constructed using the Kaplan-Meier method, with differences assessed using the log-rank test. Additionally, multivariable analysis was conducted using the Cox proportional hazard model. A total of 82 cases meeting the inclusion criteria were enrolled in the study. Management patterns varied widely, with the majority undergoing surgery (73.2%), followed by definitive radiotherapy with or without chemotherapy (10.9%), neoadjuvant radiotherapy and subsequent surgery (4.9%), and palliative care (10.9%). Post-operative radiotherapy was administered in 31.7% of cases. The disease-specific recurrence rate was found to be 32.9%, and the mortality rate was 30.5%. The median Disease-Free Survival (DFS) was 17 months (interquartile range [IQR]: 1–36 months), while the Overall Survival (OS) was 27 months (IQR: 9–52 months). Upon application of the 2021 staging system, a stage shift was observed in 18% of cases of advanced vulvar cancer. The 3-year DFS and OS were reduced for stage IIIA and stage IVA, while showing improvement for stage IIIB. The revised FIGO 2021 staging system offers enhanced simplicity in its application within clinical practice and demonstrates improved correlation with prognosis. Approximately 18% cases experienced restaging under the updated system. Not applicable.
- 18 December 2024
- Published by Springer Nature in World Journal of Surgical Oncology
- Vol. 22 (1) , 1-8
Open AccessPatterns of care for vulvar cancer and insights from revised FIGO staging: a retrospective study
The objective of this study was to evaluate the clinicopathological characteristics and patterns of care among women diagnosed with vulvar malignancy at a tertiary care teaching institute. Additionally, the study aimed to analyse the implications of revised FIGO staging system on stage shift and patient outcomes. A retrospective observational study was conducted, wherein hospital records of biopsy-proven cases of vulvar cancers managed over a period of 10 years were comprehensively reviewed. The assignment of FIGO staging was performed utilizing both 2009 and 2021 FIGO staging systems for comparative analysis. Statistical analysis was performed using STATA version 17. Survival curves were constructed using the Kaplan-Meier method, with differences assessed using the log-rank test. Additionally, multivariable analysis was conducted using the Cox proportional hazard model. A total of 82 cases meeting the inclusion criteria were enrolled in the study. Management patterns varied widely, with the majority undergoing surgery (73.2%), followed by definitive radiotherapy with or without chemotherapy (10.9%), neoadjuvant radiotherapy and subsequent surgery (4.9%), and palliative care (10.9%). Post-operative radiotherapy was administered in 31.7% of cases. The disease-specific recurrence rate was found to be 32.9%, and the mortality rate was 30.5%. The median Disease-Free Survival (DFS) was 17 months (interquartile range [IQR]: 1–36 months), while the Overall Survival (OS) was 27 months (IQR: 9–52 months). Upon application of the 2021 staging system, a stage shift was observed in 18% of cases of advanced vulvar cancer. The 3-year DFS and OS were reduced for stage IIIA and stage IVA, while showing improvement for stage IIIB. The revised FIGO 2021 staging system offers enhanced simplicity in its application within clinical practice and demonstrates improved correlation with prognosis. Approximately 18% cases experienced restaging under the updated system. Not applicable.
- 7 September 2023
- Published by Springer Nature in The Journal of Obstetrics and Gynecology of India
- Vol. 73 (S1) , 75-82
Role of Placental Vascularization Indices and Shear Wave Elastography in Fetal Growth Restriction
Objective To evaluate the role of placental vascularisation indices using 3D-Power Doppler and placental elasticity using Shear Wave Elastography (SWE) in Fetal Growth Restricted (FGR) pregnancies and to assess their correlation with perinatal outcomes. Methods This prospective case–control study was conducted from June 2018–2020. Thirty women with FGR and thirty controls (24–36 weeks) underwent grayscale and Doppler ultrasonography followed by measurement of vascularisation indices and SWE from the central and peripheral parts of fetal and maternal surfaces of the placenta. Participants were followed till delivery and perinatal outcomes were noted. Results Vascularisation indices were significantly reduced among FGR vs. controls: Vascularisation Index (VI): 20.90 ± 5.46 vs. 31.49 ± 3.89, Flow Index (FI): 26.29 ± 1.70 vs. 30.85 ± 2.02, Vascularisation- Flow Index (VFI): 7.06 ± 2.42 vs. 12.37 ± 2.43, p < 0.001. The mean placental SWE (17.36 ± 1.50 kPa) in FGR pregnancies was significantly higher as compared to controls (4.14 ± 1.14 kPa), p < 0.001. Neonatal polycythaemia and hyperbilirubinemia were significantly increased in FGR pregnancies with higher SWE value. Receiver operating characteristic curve-based cut-off of VI for intensive care requirement was 23.0 (sensitivity: 75%, specificity: 71%) and for tachypnea was 22.8 (73% sensitivity and specificity). The cut-off of FI for low birth weight was 25.7 (sensitivity: 69.6%, specificity: 71.4%). Conclusion This study demonstrates that increased placental stiffness and reduced vascularisation in FGR indicate possible placental pathology. Both modalities help in predicting perinatal complications. Hence, vascularisation indices and SWE reflect the extent of placental insufficiency and can be useful adjuncts in diagnosis.
- 7 September 2023
- Published by Springer Nature in The Journal of Obstetrics and Gynecology of India
- Vol. 73 (S1) , 75-82
Role of Placental Vascularization Indices and Shear Wave Elastography in Fetal Growth Restriction
Objective To evaluate the role of placental vascularisation indices using 3D-Power Doppler and placental elasticity using Shear Wave Elastography (SWE) in Fetal Growth Restricted (FGR) pregnancies and to assess their correlation with perinatal outcomes. Methods This prospective case–control study was conducted from June 2018–2020. Thirty women with FGR and thirty controls (24–36 weeks) underwent grayscale and Doppler ultrasonography followed by measurement of vascularisation indices and SWE from the central and peripheral parts of fetal and maternal surfaces of the placenta. Participants were followed till delivery and perinatal outcomes were noted. Results Vascularisation indices were significantly reduced among FGR vs. controls: Vascularisation Index (VI): 20.90 ± 5.46 vs. 31.49 ± 3.89, Flow Index (FI): 26.29 ± 1.70 vs. 30.85 ± 2.02, Vascularisation- Flow Index (VFI): 7.06 ± 2.42 vs. 12.37 ± 2.43, p < 0.001. The mean placental SWE (17.36 ± 1.50 kPa) in FGR pregnancies was significantly higher as compared to controls (4.14 ± 1.14 kPa), p < 0.001. Neonatal polycythaemia and hyperbilirubinemia were significantly increased in FGR pregnancies with higher SWE value. Receiver operating characteristic curve-based cut-off of VI for intensive care requirement was 23.0 (sensitivity: 75%, specificity: 71%) and for tachypnea was 22.8 (73% sensitivity and specificity). The cut-off of FI for low birth weight was 25.7 (sensitivity: 69.6%, specificity: 71.4%). Conclusion This study demonstrates that increased placental stiffness and reduced vascularisation in FGR indicate possible placental pathology. Both modalities help in predicting perinatal complications. Hence, vascularisation indices and SWE reflect the extent of placental insufficiency and can be useful adjuncts in diagnosis.
- Open Access
- 1 January 2023
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 34 (1)
Asian Young Doctors Session at the 64th Annual Meeting of the Japanese Society for Gynecologic Oncology (JSGO): Educational Initiatives in the Next Generation for a New Era after the COVID-19 Pandemic
Kobayashi Y, et al. J Gynecol Oncol. 2022 Nov;34(1):e22. https://doi.org/10.3802/jgo.2023.34.e22
- 1 January 2023
- Published by XMLink in Journal of Gynecologic Oncology
- Vol. 34 (1)
Open AccessAsian Young Doctors Session at the 64th Annual Meeting of the Japanese Society for Gynecologic Oncology (JSGO): Educational Initiatives in the Next Generation for a New Era after the COVID-19 Pandemic
Kobayashi Y, et al. J Gynecol Oncol. 2022 Nov;34(1):e22. https://doi.org/10.3802/jgo.2023.34.e22
- Open Access
- 27 June 2022
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 19 (2) , 111-117
Outcome in women undergoing uterine artery embolization for arterio-venous malformation diagnosed post-pregnancy-A retrospective study
Objective: To analyse the outcome of patients with symptomatic arterio-venous malformation (AVM), formed following pregnancy and managed by uterine artery embolization (UAE). Materials and Methods: This retrospective study was conducted after ethical approval and included 15 patients presenting with abnormal uterine bleeding following pregnancy, who were suspected to have an AVM which later was confirmed by angiography and managed with UAE. Presenting symptoms, postUAE complications and subsequent fertility outcomes were noted. Follow-up period ranged from 6 months to 2.5 years. Results: The mean age was 28.4 +/- 3.82 years and mean parity was 1.3. Out of 15 cases, 9 (60%) presented after abortion, 4 (26.6%) after normal vaginal delivery and 2 (13.3%) after cesarean delivery; of these 10/15 (66.7%) patients had a history of curettage. The most common presenting symptom was continuous bleeding per-vaginum since the antecedent pregnancy in 9/15 (60%) patients and 6/15 (40%) patients had irregular bleeding. The mean duration of symptoms was 91 +/- 85.7 (30-360) days. For UAE, embolic agents used were polyvinyl alcohol (PVA) particles (300-500 mu m) in 2 (13.3%), 30% glue injection in 3 (20%), the combination of PVA with glue injection in 4 (26.6%) and PVA with gelfoam in 6 (40%) patients. After UAE, bleeding responded within 3.6 +/- 0.97 (3-6) days in all but one patient who required repeat UAE one month later. All women resumed their normal menstrual cycle in 31.3 +/- 5.2 (24-42) days. Ten patients desired conception, of whom 5 (50%) conceived within 13.2 +/- 5.1 (6-19) months after UAE. Two women carried pregnancy to term, one underwent preterm cesarean for growth restriction with oligohydramnios. One patient had postpartum hemorrhage, which was managed medically. One had spontaneous abortion at 6 weeks gestation and the other is 13 weeks pregnant at present. Conclusion: UAE is an effective treatment modality for the management of symptomatic post-pregnancy AVMs.
- 27 June 2022
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 19 (2) , 111-117
Open AccessOutcome in women undergoing uterine artery embolization for arterio-venous malformation diagnosed post-pregnancy-A retrospective study
Objective: To analyse the outcome of patients with symptomatic arterio-venous malformation (AVM), formed following pregnancy and managed by uterine artery embolization (UAE). Materials and Methods: This retrospective study was conducted after ethical approval and included 15 patients presenting with abnormal uterine bleeding following pregnancy, who were suspected to have an AVM which later was confirmed by angiography and managed with UAE. Presenting symptoms, postUAE complications and subsequent fertility outcomes were noted. Follow-up period ranged from 6 months to 2.5 years. Results: The mean age was 28.4 +/- 3.82 years and mean parity was 1.3. Out of 15 cases, 9 (60%) presented after abortion, 4 (26.6%) after normal vaginal delivery and 2 (13.3%) after cesarean delivery; of these 10/15 (66.7%) patients had a history of curettage. The most common presenting symptom was continuous bleeding per-vaginum since the antecedent pregnancy in 9/15 (60%) patients and 6/15 (40%) patients had irregular bleeding. The mean duration of symptoms was 91 +/- 85.7 (30-360) days. For UAE, embolic agents used were polyvinyl alcohol (PVA) particles (300-500 mu m) in 2 (13.3%), 30% glue injection in 3 (20%), the combination of PVA with glue injection in 4 (26.6%) and PVA with gelfoam in 6 (40%) patients. After UAE, bleeding responded within 3.6 +/- 0.97 (3-6) days in all but one patient who required repeat UAE one month later. All women resumed their normal menstrual cycle in 31.3 +/- 5.2 (24-42) days. Ten patients desired conception, of whom 5 (50%) conceived within 13.2 +/- 5.1 (6-19) months after UAE. Two women carried pregnancy to term, one underwent preterm cesarean for growth restriction with oligohydramnios. One patient had postpartum hemorrhage, which was managed medically. One had spontaneous abortion at 6 weeks gestation and the other is 13 weeks pregnant at present. Conclusion: UAE is an effective treatment modality for the management of symptomatic post-pregnancy AVMs.
- Open Access
- 11 April 2022
- Published by Springer Nature in Cureus
- Vol. 14 (4) , e24040
The Impact of the COVID-19 Pandemic on the Psychological Well-being of Healthcare Workers in Obstetrics and Gynaecology: An Observational Study at an Apex Institute
The coronavirus disease 2019 (COVID-19) pandemic has affected the health, social, and economic sectors all over the world. With a view to assessing the impact of COVID-19 on the mental health of healthcare workers (HCWs), we conducted a study to find out the incidence and severity of depression, anxiety, and post-traumatic stress disorder (PTSD) among HCWs. This was an observational cross-sectional study conducted in the Department of Obstetrics and Gynaecology in collaboration with the Department of Psychiatry at AIIMS, New Delhi from March 2021 to June 2021. One hundred HCWs working in the Department of Obstetrics and Gynaecology were surveyed using a set of semi-structured interview schedules and structured questionnaires distributed via email or manually. The structured questionnaire included the demographic profile; other baseline information; the 42-item Depression, Anxiety, and Stress Scale (DASS-42); and the Impact of Event Scale-Revised (IES-R) instrument. Data analysis was carried out using the statistical package STATA version 14.0 (StataCorp LLC, College Station, TX). A total of 100 HCWs participated in the study, out of which 39 (39%), 45 (45%), and 16 (16%) were doctors, nursing staff, and supporting staff, respectively. Overall, 92 (92%) of the participants were women, and the mean age of the participants was 29.87 ±4.85 years. Out of the 100 participants, 17 (17%), 25 (25%), 13 (13%), and two (2%) participants had depression, anxiety, stress, and PTSD, respectively. Occupation-wise, among the nursing staff, doctors, and supporting staff, the incidence of depression was 24.4%, 15.4%, 0.0%, respectively; the anxiety rate was 33.3%, 25.6%, and 0.0%, respectively; and the rate of stress was 17.8%, 12.8%, and 0.0%, respectively. The IES-R score was significantly higher among unmarried as compared to married participants (2.70 ±7.935 vs. 1.60 ±3.583, p=0.000). Participants living in joint families had a higher DASS-42 score (DASS-D: 4.00 ±5.299 vs. 3.77 ±7.727, p=0.889; DASS-A: 4.31 ±4.398 vs. 4.12 ±7.496, p=0.905; DASS-S: 4.08 ±4.816 vs. 3.88 ±7.567, p=0.016) and lower IES-R score (1.31 ±4.922 vs. 2.66 ±9.947, p=0.752) as compared to those living in nuclear families. Depression (4.86 ±8.165 vs. 2.00 ±4.388, p=0.054), anxiety (5.31 ±7.538 vs. 2.14 ±4.704, p=0.024), stress (5.20 ±7.651 vs. 1.67 ±4.733, p=0.014) and PTSD (3.61 ±10.900 vs. 1.44 ±2.634, p=0.245) were all higher among HCWs having exposure to COVID-19 more than 10 hours per week compared to participants with an exposure of less than 10 hours per week. The participants having psychiatric illness in the family showed significantly higher mean values for DASS-42 (DASS-D: 20.00 ±26.870 vs. 3.50 ±6.264, p=0.001; DASS-A: 18.50 ±20.506 vs. 3.88 ±6.215, p=0.002; DASS-S: 18.00 ±21.213 vs. 3.64 ±6.346, p=0.003) as compared to those without any psychiatric illness in the family. Based on our findings, occupational and environmental factors at the workplace play a key role in mental health outcomes, and COVID-19 has had a significant impact on the mental health of HCWs. Furthermore, we have also observed that effective planning can significantly reduce mental stress.
- 11 April 2022
- Published by Springer Nature in Cureus
- Vol. 14 (4) , e24040
Open AccessThe Impact of the COVID-19 Pandemic on the Psychological Well-being of Healthcare Workers in Obstetrics and Gynaecology: An Observational Study at an Apex Institute
The coronavirus disease 2019 (COVID-19) pandemic has affected the health, social, and economic sectors all over the world. With a view to assessing the impact of COVID-19 on the mental health of healthcare workers (HCWs), we conducted a study to find out the incidence and severity of depression, anxiety, and post-traumatic stress disorder (PTSD) among HCWs. This was an observational cross-sectional study conducted in the Department of Obstetrics and Gynaecology in collaboration with the Department of Psychiatry at AIIMS, New Delhi from March 2021 to June 2021. One hundred HCWs working in the Department of Obstetrics and Gynaecology were surveyed using a set of semi-structured interview schedules and structured questionnaires distributed via email or manually. The structured questionnaire included the demographic profile; other baseline information; the 42-item Depression, Anxiety, and Stress Scale (DASS-42); and the Impact of Event Scale-Revised (IES-R) instrument. Data analysis was carried out using the statistical package STATA version 14.0 (StataCorp LLC, College Station, TX). A total of 100 HCWs participated in the study, out of which 39 (39%), 45 (45%), and 16 (16%) were doctors, nursing staff, and supporting staff, respectively. Overall, 92 (92%) of the participants were women, and the mean age of the participants was 29.87 ±4.85 years. Out of the 100 participants, 17 (17%), 25 (25%), 13 (13%), and two (2%) participants had depression, anxiety, stress, and PTSD, respectively. Occupation-wise, among the nursing staff, doctors, and supporting staff, the incidence of depression was 24.4%, 15.4%, 0.0%, respectively; the anxiety rate was 33.3%, 25.6%, and 0.0%, respectively; and the rate of stress was 17.8%, 12.8%, and 0.0%, respectively. The IES-R score was significantly higher among unmarried as compared to married participants (2.70 ±7.935 vs. 1.60 ±3.583, p=0.000). Participants living in joint families had a higher DASS-42 score (DASS-D: 4.00 ±5.299 vs. 3.77 ±7.727, p=0.889; DASS-A: 4.31 ±4.398 vs. 4.12 ±7.496, p=0.905; DASS-S: 4.08 ±4.816 vs. 3.88 ±7.567, p=0.016) and lower IES-R score (1.31 ±4.922 vs. 2.66 ±9.947, p=0.752) as compared to those living in nuclear families. Depression (4.86 ±8.165 vs. 2.00 ±4.388, p=0.054), anxiety (5.31 ±7.538 vs. 2.14 ±4.704, p=0.024), stress (5.20 ±7.651 vs. 1.67 ±4.733, p=0.014) and PTSD (3.61 ±10.900 vs. 1.44 ±2.634, p=0.245) were all higher among HCWs having exposure to COVID-19 more than 10 hours per week compared to participants with an exposure of less than 10 hours per week. The participants having psychiatric illness in the family showed significantly higher mean values for DASS-42 (DASS-D: 20.00 ±26.870 vs. 3.50 ±6.264, p=0.001; DASS-A: 18.50 ±20.506 vs. 3.88 ±6.215, p=0.002; DASS-S: 18.00 ±21.213 vs. 3.64 ±6.346, p=0.003) as compared to those without any psychiatric illness in the family. Based on our findings, occupational and environmental factors at the workplace play a key role in mental health outcomes, and COVID-19 has had a significant impact on the mental health of HCWs. Furthermore, we have also observed that effective planning can significantly reduce mental stress.